Vukmir campaign: UNC/Harvard study proves Vukmir right on oral chemotherapy

Contact: Jessica Ward, (608) 213-5939

Policy Increased Costs Of Oral Chemotherapy For Some By Nearly $150 Per Month

Brookfield, Wis. — A study from the University of North Carolina Lineberger Comprehensive Cancer Center and Harvard Medical School proves nurse and U.S. Senate candidate Leah Vukmir right on the unintended consequences of the oral chemotherapy price-fixing bill she voted against in 2014.

For cancer patients who had the highest medication costs for oral chemotherapy, costs increased an additional $150 per month after state laws like the one in Wisconsin were passed, the researchers say.

“Per usual, Tammy Baldwin supports policies that raise health care costs for Wisconsin’s neediest patients, just like she will with her government-run health care plan that eliminates Medicare, Medicaid, Tricare andemployee health insurance,” said campaign manager Jess Ward. “As a nurse, Leah knows the best way to lower the cost of prescription drugs and cover those with pre-existing conditions is to add more choices and competition, not to add more government regulation.”
BACKGROUND… 

Cancer drug parity laws lower costs for many, but not everyone. “For those whose costs were more expensive than 95 percent of other patients, their out-of-pocket costs increased an estimated $143.25 per month. Those paying more than 90 percent of what other patients paid saw their costs increase by $37.19 per month.” (UNC Lineberger Comprehensive Cancer Center, 11/9/2017)

SHARE